Partners and Network

Networking is a central element of scientific work. We at XNApharma promote and strengthen our relationship to Universities, Hospitals and partners in other companies. Together we not only work on shared projects, we also provide an acedemic environment for our team to develop themself and perform Master- and PhD theses. Embedded into an active scientific community we are focussed to push drug candidates into clinical development to provide patients the best-in-class therapy.

Partners in our network:

• Friedrich-Schiller-University and University Hospital Jena, Germany
• Ionovation GmbH, Germany
• Pramo Molecular GmbH, Germany
• Friedrich-Alexander-University Erlangen, Germany
• Leibniz-Institut für Photonische Technologien Jena e. V.
• Intana Bioscience GmbH
• Kapelan Bio-Imaging GmbH
• Leiden University
• and many more...

XNApharma is greatly supported by public funding from the state of Thuringia and the European Union (preparative HPLC system for purification of therapeutic oligonucleotides in 2025 and a LC/MS for oligonucleotide analytics in 2026) as well as funds from the Federal Republic of Germany from the Central Innovation Program for SMEs (ZIM; Smarties).

The installation of the preparative HPLC system has massively increased the quality and efficiency of the oligonucleotide purification workflow; the LC/MS strengthens the analytical capacities and allows state-of-the-art oligonucleotide and impurity analytics.